Lysophosphatidylcholine as a ligand for immunoregulation

Janusz H S Kabarowski, Yan Xu, Owen N. Witte

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Despite the recognized effects of lysophosphatidylcholine upon cells of the immune system and its association with inflammatory processes, its mechanism of action has remained poorly characterized. Our recent identification of the first lysophosphatidylcholine receptor as an immunoregulatory G protein-coupled receptor named G2A whose genetic ablation results in the development of inflammatory autoimmune disease has, therefore, provided a new perspective on the role of this lysophospholipid as a modulator of immune responses. This commentary discusses the biological properties of lysophosphatidylcholine as an immunoregulatory ligand for cells of the innate and adaptive arms of the immune system. Although we focus primarily on ligand interactions with G2A, we also discuss the issue of possible functional redundancy with other receptors with recently established ligand specificities towards phosphorylcholine-containing lysolipids including lysophosphatidylcholine.

Original languageEnglish (US)
Pages (from-to)161-167
Number of pages7
JournalBiochemical Pharmacology
Volume64
Issue number2
DOIs
StatePublished - Jul 15 2002
Externally publishedYes

Fingerprint

Lysophosphatidylcholines
Ligands
Immune system
Immune System
Lysophospholipids
Phosphorylcholine
G-Protein-Coupled Receptors
Ablation
Modulators
Autoimmune Diseases
Redundancy

Keywords

  • Immune regulation
  • Inflammation
  • Lysophosphatidylcholine
  • Oxidized low density lipoprotein
  • Phospholipase A
  • Systemic autoimmune disease

ASJC Scopus subject areas

  • Pharmacology

Cite this

Lysophosphatidylcholine as a ligand for immunoregulation. / Kabarowski, Janusz H S; Xu, Yan; Witte, Owen N.

In: Biochemical Pharmacology, Vol. 64, No. 2, 15.07.2002, p. 161-167.

Research output: Contribution to journalArticle

Kabarowski, Janusz H S ; Xu, Yan ; Witte, Owen N. / Lysophosphatidylcholine as a ligand for immunoregulation. In: Biochemical Pharmacology. 2002 ; Vol. 64, No. 2. pp. 161-167.
@article{c2ead8a6ba664fc0aafa1ecd203958c3,
title = "Lysophosphatidylcholine as a ligand for immunoregulation",
abstract = "Despite the recognized effects of lysophosphatidylcholine upon cells of the immune system and its association with inflammatory processes, its mechanism of action has remained poorly characterized. Our recent identification of the first lysophosphatidylcholine receptor as an immunoregulatory G protein-coupled receptor named G2A whose genetic ablation results in the development of inflammatory autoimmune disease has, therefore, provided a new perspective on the role of this lysophospholipid as a modulator of immune responses. This commentary discusses the biological properties of lysophosphatidylcholine as an immunoregulatory ligand for cells of the innate and adaptive arms of the immune system. Although we focus primarily on ligand interactions with G2A, we also discuss the issue of possible functional redundancy with other receptors with recently established ligand specificities towards phosphorylcholine-containing lysolipids including lysophosphatidylcholine.",
keywords = "Immune regulation, Inflammation, Lysophosphatidylcholine, Oxidized low density lipoprotein, Phospholipase A, Systemic autoimmune disease",
author = "Kabarowski, {Janusz H S} and Yan Xu and Witte, {Owen N.}",
year = "2002",
month = "7",
day = "15",
doi = "10.1016/S0006-2952(02)01179-6",
language = "English (US)",
volume = "64",
pages = "161--167",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Lysophosphatidylcholine as a ligand for immunoregulation

AU - Kabarowski, Janusz H S

AU - Xu, Yan

AU - Witte, Owen N.

PY - 2002/7/15

Y1 - 2002/7/15

N2 - Despite the recognized effects of lysophosphatidylcholine upon cells of the immune system and its association with inflammatory processes, its mechanism of action has remained poorly characterized. Our recent identification of the first lysophosphatidylcholine receptor as an immunoregulatory G protein-coupled receptor named G2A whose genetic ablation results in the development of inflammatory autoimmune disease has, therefore, provided a new perspective on the role of this lysophospholipid as a modulator of immune responses. This commentary discusses the biological properties of lysophosphatidylcholine as an immunoregulatory ligand for cells of the innate and adaptive arms of the immune system. Although we focus primarily on ligand interactions with G2A, we also discuss the issue of possible functional redundancy with other receptors with recently established ligand specificities towards phosphorylcholine-containing lysolipids including lysophosphatidylcholine.

AB - Despite the recognized effects of lysophosphatidylcholine upon cells of the immune system and its association with inflammatory processes, its mechanism of action has remained poorly characterized. Our recent identification of the first lysophosphatidylcholine receptor as an immunoregulatory G protein-coupled receptor named G2A whose genetic ablation results in the development of inflammatory autoimmune disease has, therefore, provided a new perspective on the role of this lysophospholipid as a modulator of immune responses. This commentary discusses the biological properties of lysophosphatidylcholine as an immunoregulatory ligand for cells of the innate and adaptive arms of the immune system. Although we focus primarily on ligand interactions with G2A, we also discuss the issue of possible functional redundancy with other receptors with recently established ligand specificities towards phosphorylcholine-containing lysolipids including lysophosphatidylcholine.

KW - Immune regulation

KW - Inflammation

KW - Lysophosphatidylcholine

KW - Oxidized low density lipoprotein

KW - Phospholipase A

KW - Systemic autoimmune disease

UR - http://www.scopus.com/inward/record.url?scp=0037099201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037099201&partnerID=8YFLogxK

U2 - 10.1016/S0006-2952(02)01179-6

DO - 10.1016/S0006-2952(02)01179-6

M3 - Article

VL - 64

SP - 161

EP - 167

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 2

ER -